Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

Amyloidosis pertains to a group of diseases caused by the abnormal folding and then accumulation of protein in various parts of the body. Sometimes, these proteins are deposited in the heart resulting in cardiac amyloidosis. Cardiac amyloidosis is thought to be a rare disease, however, recent advances in diagnostic testing developed at Boston Medical Center in collaboration with other experts across the world suggest that it is likely more common than is presently appreciated.

BMC is an international referral center for the diagnosis and treatment of systemic amyloid diseases. BMC is one of the few hospitals nationwide that offers innovative treatments for amyloidosis, including stem cell transplantation for light-chain (AL) amyloidosis, with numerous ongoing clinical trials for all types of amyloidosis. The Amyloidosis Center, founded in 1960, employs a multidisciplinary approach to this disorder that frequently affects multiple organ systems. Cardiologists diagnose and treat the damage amyloidosis can cause to the heart and coordinate innovative care with other specialists at BMC.

Areas of active clinical research relevant to cardiac amyloidosis include cardiac imaging that uses magnetic resonance imaging (MRI) and nuclear imaging (using the pyrophosphate or PYP scan), studies examining the biochemical basis of amyloid toxicity, and projects examining the best treatment of patients with cardiac amyloidosis.

For further information regarding the program or ongoing research studies, or to refer a patient with amyloidosis, please contact the program office at 617.638.4317 or visit the Amyloid Center Webpage.

Departments and Programs Who Treat This Condition

department

Cardiovascular Center

Our expert, multidisciplinary team offers a wide range of services to both treat and prevent cardiac diseases and conditions. From stents to smoking cessation, we can help you kee…
department

Amyloidosis Center

Boston Medical Center is an international referral center that provides multi-disciplinary diagnosis and treatment of all types of amyloidosis, a rare group of diseases.